Clinical Trials Directory

Trials / Completed

CompletedNCT05413720

Study of the Innate Immune Response to the Acute Phase of Human Leptospirosis - IMMUNOLEPTO

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Centre Hospitalier Universitaire de la Réunion · Academic / Other
Sex
All
Age
4 Years
Healthy volunteers
Not accepted

Summary

The research hypothesis is based on a suspected strong involvement of the immune system in the genesis of serious manifestations of the disease (hepatitis, renal failure, thrombocytopenia, intra-alveolar hemorrhage). The question asked is that of the state of the immune system (quantitative and qualitative: activation markers, production of cytokines) evaluated by the study of circulating innate immune cells (monocytes, neutrophils, dendritic cells, lymphocytes, platelets).

Conditions

Interventions

TypeNameDescription
OTHERtwo additional blood samples specific to researchproportion of activated monocyte cells (CD14+CD16+ phenotype) within monocytes in the acute phase

Timeline

Start date
2021-01-06
Primary completion
2022-07-20
Completion
2022-07-20
First posted
2022-06-10
Last updated
2023-10-25

Locations

4 sites across 1 country: Reunion

Source: ClinicalTrials.gov record NCT05413720. Inclusion in this directory is not an endorsement.